- September 16, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Gastroenterology » Stomach » Peptic Ulcer Disease
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Gastroenterology » Stomach » Peptic Ulcer Disease
Background
Peptic ulcer disease (PUD) is defined by a discontinuity in the gastrointestinal inner lining brought on by pepsin or gastric acid release. Usually occurring in the stomach or proximal duodenum, peptic ulcers are acid-induced lesions of the digestive system depicted by denuded mucosa with damage extending into the muscularis propria or submucosa.
Patients with gastric ulcers often have epigastric discomfort 15 to 30 minutes after eating; in contrast, patients with duodenal ulcers typically experience pain 2 to 3 hours after eating meals.
Epidemiology
With a lifetime development risk of between 5% and 10%, peptic ulcer disease is widespread. Globally, peptic ulcer disease incidence has decreased due to improved hygienic and sanitary settings, competent medical care, and prudent NSAID use. Additionally, men are more likely than women to develop duodenal ulcers.
Anatomy
Pathophysiology
The protective mucosal lining of the stomach and duodenum is damaged, which leads to the ulcerogenic process. It is well understood that H. pylori infections, the use of NSAIDs, and low-dose aspirin cause mucosal lining damage. Both bacterial causes and the host’s inflammatory response have a role in the cost to the mucosal lining in the context of an H. pylori infection.
Mucosal damage caused by the use of NSAIDs results from the suppression of prostaglandins produced by the enzyme cyclooxygenase 1 (COX-1), which are essential for preserving mucosal integrity. The ulcerative process begins when the mucosal layer is damaged, exposing the stomach epithelium to acid. If the situation persists, the ulcer will develop until it reaches the serosal layer.
Etiology
NSAID-induced
Nonsteroidal anti-inflammatory drugs are the second most frequent cause of peptic ulcer disease. Prostaglandin is often secreted to protect the stomach mucosa. By inhibiting the COX-1 enzyme, NSAIDs prevent the creation of prostaglandins, which lowers the production of gastrointestinal mucus, bicarbonate, and mucosal blood flow.
H. pylori associated Peptic Ulcer
The stomach epithelial cells contain the gram-negative bacillus H. pylorus. These bacteria lead on 90% of duodenal ulcers and 70% of stomach ulcers. Lower socioeconomic status individuals are more likely to have H. pylori infection, frequently acquired during childhood. The bacteria may attach to and inflame the stomach mucosa due to a broad spectrum of virulence factors.
In addition to NSAIDs, corticosteroids, bisphosphonates, potassium chloride, and fluorouracil have all been linked to PUD’s pathogenesis. Smoking tends to be associated with duodenal ulcers; however, the relationship is not linear. Alcohol can trigger acidity by irritating the stomach mucosa.
Genetics
Prognostic Factors
After the condition’s underlying cause is adequately managed, the prognosis for peptic ulcer disease is favorable. The ulcer’s recurrence may be avoided by practicing proper hygiene and avoiding NSAIDs, alcohol, and smoking.
However, recurrence is frequent, with rates in most cases reaching 60%. Gastric perforation spurred on NSAIDs occurs in one patient every year at a rate of 0.3%. However, peptic ulcer disease death rates have declined.
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Administer 5 to 30ml between meals and at bedtime
5 to 10 mg administered orally twice or thrice a day
The suggested dose is 50 mg orally thrice a day
Future Trends
References
https://www.ncbi.nlm.nih.gov/books/NBK534792/
ADVERTISEMENT
» Home » CAD » Gastroenterology » Stomach » Peptic Ulcer Disease
Peptic ulcer disease (PUD) is defined by a discontinuity in the gastrointestinal inner lining brought on by pepsin or gastric acid release. Usually occurring in the stomach or proximal duodenum, peptic ulcers are acid-induced lesions of the digestive system depicted by denuded mucosa with damage extending into the muscularis propria or submucosa.
Patients with gastric ulcers often have epigastric discomfort 15 to 30 minutes after eating; in contrast, patients with duodenal ulcers typically experience pain 2 to 3 hours after eating meals.
With a lifetime development risk of between 5% and 10%, peptic ulcer disease is widespread. Globally, peptic ulcer disease incidence has decreased due to improved hygienic and sanitary settings, competent medical care, and prudent NSAID use. Additionally, men are more likely than women to develop duodenal ulcers.
The protective mucosal lining of the stomach and duodenum is damaged, which leads to the ulcerogenic process. It is well understood that H. pylori infections, the use of NSAIDs, and low-dose aspirin cause mucosal lining damage. Both bacterial causes and the host’s inflammatory response have a role in the cost to the mucosal lining in the context of an H. pylori infection.
Mucosal damage caused by the use of NSAIDs results from the suppression of prostaglandins produced by the enzyme cyclooxygenase 1 (COX-1), which are essential for preserving mucosal integrity. The ulcerative process begins when the mucosal layer is damaged, exposing the stomach epithelium to acid. If the situation persists, the ulcer will develop until it reaches the serosal layer.
NSAID-induced
Nonsteroidal anti-inflammatory drugs are the second most frequent cause of peptic ulcer disease. Prostaglandin is often secreted to protect the stomach mucosa. By inhibiting the COX-1 enzyme, NSAIDs prevent the creation of prostaglandins, which lowers the production of gastrointestinal mucus, bicarbonate, and mucosal blood flow.
H. pylori associated Peptic Ulcer
The stomach epithelial cells contain the gram-negative bacillus H. pylorus. These bacteria lead on 90% of duodenal ulcers and 70% of stomach ulcers. Lower socioeconomic status individuals are more likely to have H. pylori infection, frequently acquired during childhood. The bacteria may attach to and inflame the stomach mucosa due to a broad spectrum of virulence factors.
In addition to NSAIDs, corticosteroids, bisphosphonates, potassium chloride, and fluorouracil have all been linked to PUD’s pathogenesis. Smoking tends to be associated with duodenal ulcers; however, the relationship is not linear. Alcohol can trigger acidity by irritating the stomach mucosa.
After the condition’s underlying cause is adequately managed, the prognosis for peptic ulcer disease is favorable. The ulcer’s recurrence may be avoided by practicing proper hygiene and avoiding NSAIDs, alcohol, and smoking.
However, recurrence is frequent, with rates in most cases reaching 60%. Gastric perforation spurred on NSAIDs occurs in one patient every year at a rate of 0.3%. However, peptic ulcer disease death rates have declined.
Administer 5 to 30ml between meals and at bedtime
5 to 10 mg administered orally twice or thrice a day
The suggested dose is 50 mg orally thrice a day
https://www.ncbi.nlm.nih.gov/books/NBK534792/
Peptic ulcer disease (PUD) is defined by a discontinuity in the gastrointestinal inner lining brought on by pepsin or gastric acid release. Usually occurring in the stomach or proximal duodenum, peptic ulcers are acid-induced lesions of the digestive system depicted by denuded mucosa with damage extending into the muscularis propria or submucosa.
Patients with gastric ulcers often have epigastric discomfort 15 to 30 minutes after eating; in contrast, patients with duodenal ulcers typically experience pain 2 to 3 hours after eating meals.
With a lifetime development risk of between 5% and 10%, peptic ulcer disease is widespread. Globally, peptic ulcer disease incidence has decreased due to improved hygienic and sanitary settings, competent medical care, and prudent NSAID use. Additionally, men are more likely than women to develop duodenal ulcers.
The protective mucosal lining of the stomach and duodenum is damaged, which leads to the ulcerogenic process. It is well understood that H. pylori infections, the use of NSAIDs, and low-dose aspirin cause mucosal lining damage. Both bacterial causes and the host’s inflammatory response have a role in the cost to the mucosal lining in the context of an H. pylori infection.
Mucosal damage caused by the use of NSAIDs results from the suppression of prostaglandins produced by the enzyme cyclooxygenase 1 (COX-1), which are essential for preserving mucosal integrity. The ulcerative process begins when the mucosal layer is damaged, exposing the stomach epithelium to acid. If the situation persists, the ulcer will develop until it reaches the serosal layer.
NSAID-induced
Nonsteroidal anti-inflammatory drugs are the second most frequent cause of peptic ulcer disease. Prostaglandin is often secreted to protect the stomach mucosa. By inhibiting the COX-1 enzyme, NSAIDs prevent the creation of prostaglandins, which lowers the production of gastrointestinal mucus, bicarbonate, and mucosal blood flow.
H. pylori associated Peptic Ulcer
The stomach epithelial cells contain the gram-negative bacillus H. pylorus. These bacteria lead on 90% of duodenal ulcers and 70% of stomach ulcers. Lower socioeconomic status individuals are more likely to have H. pylori infection, frequently acquired during childhood. The bacteria may attach to and inflame the stomach mucosa due to a broad spectrum of virulence factors.
In addition to NSAIDs, corticosteroids, bisphosphonates, potassium chloride, and fluorouracil have all been linked to PUD’s pathogenesis. Smoking tends to be associated with duodenal ulcers; however, the relationship is not linear. Alcohol can trigger acidity by irritating the stomach mucosa.
After the condition’s underlying cause is adequately managed, the prognosis for peptic ulcer disease is favorable. The ulcer’s recurrence may be avoided by practicing proper hygiene and avoiding NSAIDs, alcohol, and smoking.
However, recurrence is frequent, with rates in most cases reaching 60%. Gastric perforation spurred on NSAIDs occurs in one patient every year at a rate of 0.3%. However, peptic ulcer disease death rates have declined.
https://www.ncbi.nlm.nih.gov/books/NBK534792/
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.